230 related articles for article (PubMed ID: 11942178)
1. [Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1].
Polus M; Jerusalem G; Sautois B; Silvestre RM; Collette MY; Closon MT; Fillet G
Rev Med Liege; 2002 Feb; 57(2):119-22. PubMed ID: 11942178
[TBL] [Abstract][Full Text] [Related]
2. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.
Abrams RA
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S30-2. PubMed ID: 16399427
[TBL] [Abstract][Full Text] [Related]
4. The case for routine use of adjuvant therapy in pancreatic cancer.
Kennedy EP; Yeo CJ
J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
[TBL] [Abstract][Full Text] [Related]
5. [Concomitant chemoradiotherapy and preoperative radiotherapy in exocrine pancreatic adenocarcinoma].
Mornex F; Gérard JP; Chauffert B; Brun M
Ann Chir; 2000 Feb; 125(2):111-7. PubMed ID: 10998795
[TBL] [Abstract][Full Text] [Related]
6. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
7. Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.
Bassi C; Stocken DD; Olah A; Friess H; Buckels J; Hickey H; Dervenis C; Dunn JA; Deakin M; Carter R; Ghaneh P; Neoptolemos JP; Buchler MW;
Dig Surg; 2005; 22(5):353-63. PubMed ID: 16293966
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy following resection for pancreatic adenocarcinoma.
Brennan MF
Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for pancreatic cancer: to treat or not to treat?
Berlin JD
Oncology (Williston Park); 2007 May; 21(6):712-8; discussion 720, 725-6, 730. PubMed ID: 17564327
[TBL] [Abstract][Full Text] [Related]
11. Combined-modality treatment for operable pancreatic adenocarcinoma.
Pisters PW; Wolff RA; Crane CH; Evans DB
Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies.
Kleeff J; Michalski CW; Friess H; Büchler MW
Eur J Surg Oncol; 2007 Sep; 33(7):817-23. PubMed ID: 17331695
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy in pancreatic cancer: a critical appraisal.
Oettle H; Neuhaus P
Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
Meszoely IM; Wang H; Hoffman JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
[TBL] [Abstract][Full Text] [Related]
17. Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma.
Abrams RA
Cancer J; 2012; 18(6):624-32. PubMed ID: 23187851
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
[TBL] [Abstract][Full Text] [Related]
19. Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings.
Dickler A; Abrams RA
Semin Radiat Oncol; 2005 Oct; 15(4):235-44. PubMed ID: 16183477
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant and adjuvant strategies for pancreatic cancer.
Ghaneh P; Smith R; Tudor-Smith C; Raraty M; Neoptolemos JP
Eur J Surg Oncol; 2008 Mar; 34(3):297-305. PubMed ID: 17936564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
